
Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal…

Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal…
Founded: 2016
Headquarters / Footprint: French–American company with New York headquarters and multiple global offices
Tech focus: Multimodal, agentic biomedical AI (drug discovery, clinical development, diagnostics)
Reported total funding: $304.1M
Notable strategic investor/partner: Sanofi (strategic $180M investment)
Decoding complex biology to find the right treatment for every patient; accelerating drug discovery, development, and diagnostics using AI.
2016
Biotechnology Research
180000000
Strategic investment reported as $180M alongside a multi-year oncology collaboration
25000000
Reported $25M Series A extension (reported at the time to bring total to roughly $55M)
“Has raised institutional venture capital and strategic corporate investment (including a major strategic investment from Sanofi and participation from investors such as GV, Bpifrance, F-Prime, Cathay Innovation, Eight Roads, NJF Capital, Otium/Frst, Mubadala, MACSF)”
| Company |
|---|
Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biology Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software. At the heart of this system is Owkin K, an AI copilot and its new LLM fine-tuned on biology called Owkin Zero, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster.
This is a six-month internship position is based in our Paris office.
Please submit your CV in English
The Computational Drug Discovery team within the Biomedical Department aims at bridging the gap between target discovery and preclinical drug candidates. Blending experts in machine learning, biologics, protein language models and computational chemistry, the team provides solutions in around target tractability, de novo biologics design, cheminformatics, cofolding, etc..
We are looking for a promising research intern to focus on generative approaches, particularly flow matching models. As part of the project, the intern will survey and compare existing approaches, and build workflows that fit our use cases, starting with small molecule generation constrained by binding sites. This internship provides a unique opportunity to study a fast-growing and important field, with clear applications for drug discovery.
Required qualifications / experience:
We are looking for someone with:
Preferred qualifications/bonus::
Ref: #LI-HB1
If you think that you have been a victim of fraud,
Check the identity of the talent team on LinkedIn
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,500+
New This Week
Check our senior team on our website https://owkin.com/team/
Check the existence of the position on our website: https://www.owkin.com/careers#current-opportunities
Notify Owkin's recruitment unit at this address hiring@owkin.com
contact the following authorities: